Case Study: a Japanese drug manufacturer achieves streamlined US market entry with FREYR

Japanese Drug Manufacturer streamlines US submissions and cuts dossier turnaround times with FREYR

A Japanese drug manufacturer sought to enter the US market but faced challenges with inconsistent submission processes and meeting stringent FDA timelines for multiple products. FREYR partnered with the client to provide eCTD publishing and submission support, aiming to standardize workflows and ensure regulatory compliance.

FREYR implemented a standardized publishing and submission framework, which included establishing new operating procedures, performing technical validation, and managing submission timelines. This solution improved submission consistency, enhanced operational efficiency, and achieved timely delivery of compliant dossiers, successfully supporting the client's market expansion objectives.